MedTrace Logo

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze

NCT00664391 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2009-02-10

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Breeze.

Conditions

  • Hygiene

Interventions

DRUG

Lactic acid (Dermacid)

Liquid soup to be applied in the external genital area, in small quantity, with abundantly rinse after use, during 21 days

Sponsors & Collaborators

Principal Investigators

  • Jaderson Lima · Sanofi-aventis administrative office Brazil

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-02-29

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00664391 on ClinicalTrials.gov